Tandem Diabetes Care Inc

SEC CIK #0001438133

Tandem Diabetes Care Inc is registered with the U.S. Security and Exchange Commission. This page includes all SEC filing details as well as a list of any documents (S-1, Prospecuts, Current Reports, 8-K, 10K, Annual Reports) registered by Tandem Diabetes Care Inc.

Company Details
IRS Number (EIN)204327508 ( EIN # 20-4327508)
Reporting File Number001-36189
State of IncorpporationDELAWARE
Fiscal Year End12-31
SIC3841 [SURGICAL & MEDICAL INSTRUMENTS & APPARATUS]
Business Address11075 ROSELLE STREET
San Diego CA 92121
Business Phone858-366-6900
Mailing Address11075 ROSELLE STREET
San Diego CA 92121
Legal Entity Identifier 549300JEPFOD0K4D3I05 [TANDEM DIABETES CARE, INC.]

Documents Filed
Tandem Diabetes Care Inc SEC Filings RSS Feed

Form
Title
Date
4
2019-11-18 19:12:52
4
2019-11-06 17:13:18
10-Q
2019-11-04 16:16:01
8-K
2019-11-04 16:10:01
4
2019-09-09 16:20:01
4
2019-09-03 19:27:54
4
2019-08-30 16:19:21
4
2019-08-29 19:56:38
4
2019-08-29 19:30:47
4
2019-08-28 16:09:14
4
2019-08-14 16:06:28
4
2019-08-13 16:53:25
4
2019-08-06 18:54:15
4
2019-08-06 16:17:33
4
2019-08-06 16:14:27
4
2019-08-06 16:13:23
S-8
2019-08-01 16:20:32
10-Q
2019-08-01 16:10:52
8-K
2019-08-01 16:06:16
4
2019-07-15 17:12:24
4
2019-07-12 17:43:22
4
2019-07-08 16:04:00
4
2019-06-20 18:44:32
4
2019-06-20 18:43:28
4
2019-06-20 18:42:16
4
2019-06-20 18:40:58
4
2019-06-20 18:39:39
4
2019-06-20 18:37:57
4
2019-06-20 18:31:28
8-K
2019-06-18 21:31:13
4
2019-06-17 17:02:04
DEFA14A
2019-06-14 16:01:43
8-K
2019-06-10 09:00:05
4
2019-06-04 16:46:26
DEFA14A
2019-06-04 16:02:25
DEFA14A
2019-05-30 18:24:43
SD
2019-05-30 17:00:22
DEFA14A
2019-05-22 20:45:17
8-K
2019-05-22 16:15:26
4
2019-05-17 16:44:27
4
2019-05-17 16:43:25
4
2019-05-17 16:42:01
4
2019-05-17 16:40:43
4
2019-05-17 16:38:46
4
2019-05-06 17:33:01
4
2019-05-06 17:26:14
4
2019-05-03 17:30:40
10-Q
2019-04-30 16:14:44
8-K
2019-04-30 16:10:55
DEFA14A
2019-04-11 16:22:55
[ 2 ] Next->


0-50 of 526 Results
Page: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 |

© 2019 SEC.report
SEC CFR Title 17